Match tier
Listed
Presence
Current · Arkansas
Last published
2024
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
M
Manozna Karri
Assistant Professor
Also affiliated: Campbell University (2022); Winthrop Rockefeller Foundation (2024); Southeastern Health (2022)
Faculty Researcher
COM | Internal Med Hem-Onc
1 h-index
5 pubs
3 cited
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Manozna Karri's research focuses on clinical case reports and the impact of disease and treatment on patient outcomes. Karri has investigated rare medical conditions, including inflammatory myofibroblastic tumors and drug-induced hyperprolactinemia, as documented in case reports and literature reviews. A significant area of work involves minimal residual disease (MRD) in multiple myeloma, examining its variability and dependence on molecular subgroups as defined by gene expression profiling. This research aims to understand how specific genetic markers influence clinical outcomes in patients with multiple myeloma. Karri also explores challenges in healthcare delivery, such as patient compliance in the context of telemedicine. Collaborations include work with Phillip Farmer, Hira Imad Cheema, Trilok Shrivastava, and Syed Naqvi at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 1
- Publications: 5
- Citations: 3
Selected Publications
-
Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP) (2024)
Collaboration Network
Top Collaborators
Sharmilan Thanendrarajan
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Phillip Farmer
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Clyde Bailey
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Carolina Schinke
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Samer Al Hadidi
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Maurizio Zangari
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Stephanie Rogers
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Anne M Williams
Winthrop Rockefeller Foundation (US)
1 shared publication
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Fenghuang Zhan
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
John D. Shaughnessy
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Tanvi H Patel
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Anup Kumar Trikannad
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Asis Shrestha
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Syed Naqvi
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Hira Imad Cheema
Winthrop Rockefeller Foundation
1 shared publication
In database
- Minimal Residual Disease (MRD) Status and Its Impact on Clinical Outcome Is Highly Variable in Multiple Myeloma and Dependent on Molecular Subgroups Defined By Gene Expression Profiling (GEP)
Similar Researchers
Based on overlapping research topics
Shayu Deshpande
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Telemedicine and Telehealth Implementation
Phillip Farmer
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Telemedicine and Telehealth Implementation
Zainab Atiq
University of Arkansas for Medical Sciences
Medical Case Reports
Pharmacological Effects and Toxicity Studies
Health Disparities and Outcomes
Niroshi Wijewardane
University of Arkansas for Medical Sciences
Medical Case Reports
Pharmacological Effects and Toxicity Studies
Health Disparities and Outcomes
Manuel Heredia
University of Arkansas for Medical Sciences
Multiple Myeloma Research and Treatments
Cancer-related molecular mechanisms research
Health Disparities and Outcomes
C Johnson
University of Arkansas at Fayetteville
Cancer-related molecular mechanisms research
Pharmacological Effects and Toxicity Studies
Health Disparities and Outcomes